ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Algernon Pharmaceuticals Inc (QB)

Algernon Pharmaceuticals Inc (QB) (AGNPF)

0.055
-0.014
( -20.29% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.055
Bid
0.051
Ask
0.0604
Volume
19,964
0.0549 Day's Range 0.061
0.0375 52 Week Range 0.1191
Market Cap
Previous Close
0.069
Open
0.061
Last Trade
2000
@
0.055
Last Trade Time
10:30:29
Financial Volume
US$ 1,218
VWAP
0.061
Average Volume (3m)
13,756
Shares Outstanding
28,756,219
Dividend Yield
-
PE Ratio
-2.86
Earnings Per Share (EPS)
-0.02
Revenue
-
Net Profit
-503k

About Algernon Pharmaceuticals Inc (QB)

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically inv... Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Vancouver, British Columbia, Can
Founded
-
Algernon Pharmaceuticals Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker AGNPF. The last closing price for Algernon Pharmaceuticals (QB) was US$0.07. Over the last year, Algernon Pharmaceuticals (QB) shares have traded in a share price range of US$ 0.0375 to US$ 0.1191.

Algernon Pharmaceuticals (QB) currently has 28,756,219 shares outstanding. The market capitalization of Algernon Pharmaceuticals (QB) is US$1.98 million. Algernon Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of -2.86.

AGNPF Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0163-22.86115007010.07130.07130.0549118050.0667502CS
4-0.0136-19.82507288630.06860.07130.052156440.06409008CS
12-0.0055-9.090909090910.06050.07190.0484137560.06284435CS
260.00714.58333333330.0480.090.0375153130.06375858CS
52-0.04014-42.19045616990.095140.11910.0375112980.0664903CS
156-0.7575-93.23076923080.81251.3250.0353111600.17080645CS
2600.0122528.65497076020.042752.3198750.00852152470.05605182CS

AGNPF - Frequently Asked Questions (FAQ)

What is the current Algernon Pharmaceuticals (QB) share price?
The current share price of Algernon Pharmaceuticals (QB) is US$ 0.055
How many Algernon Pharmaceuticals (QB) shares are in issue?
Algernon Pharmaceuticals (QB) has 28,756,219 shares in issue
What is the market cap of Algernon Pharmaceuticals (QB)?
The market capitalisation of Algernon Pharmaceuticals (QB) is USD 1.98M
What is the 1 year trading range for Algernon Pharmaceuticals (QB) share price?
Algernon Pharmaceuticals (QB) has traded in the range of US$ 0.0375 to US$ 0.1191 during the past year
What is the PE ratio of Algernon Pharmaceuticals (QB)?
The price to earnings ratio of Algernon Pharmaceuticals (QB) is -2.86
What is the reporting currency for Algernon Pharmaceuticals (QB)?
Algernon Pharmaceuticals (QB) reports financial results in CAD
What is the latest annual profit for Algernon Pharmaceuticals (QB)?
The latest annual profit of Algernon Pharmaceuticals (QB) is CAD -503k
What is the registered address of Algernon Pharmaceuticals (QB)?
The registered address for Algernon Pharmaceuticals (QB) is SUITE 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6E 4N7
What is the Algernon Pharmaceuticals (QB) website address?
The website address for Algernon Pharmaceuticals (QB) is www.algernonpharmaceuticals.com
Which industry sector does Algernon Pharmaceuticals (QB) operate in?
Algernon Pharmaceuticals (QB) operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VGFCQVery Good Food Company Inc (CE)
US$ 0.01
(999,900.00%)
187.79k
BIRMFBiorem Inc (PK)
US$ 1.70
(154,445.45%)
9.7k
SLNAFSelina Hospitality PLC (CE)
US$ 0.0005
(49,900.00%)
133.66k
SBESSouth Beach Spirits Inc (CE)
US$ 0.0002
(19,900.00%)
100
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.01
(9,900.00%)
100
TAYOTaylor Consulting Inc (CE)
US$ 0.000001
(-99.83%)
1,000
RGFCReal Good Food Company Inc (CE)
US$ 0.0001
(-99.80%)
898
BIMIBIMI International Medical Inc (CE)
US$ 0.0001
(-99.67%)
1,000
COGDFCompass Gold Corporation (PK)
US$ 0.0005
(-99.67%)
6.06k
SRAXSRAX Inc (CE)
US$ 0.0003
(-99.40%)
58.53k
AFFUAffluence Corp (PK)
US$ 0.0002
(42.86%)
266.11M
DRNGDrone Guarder Inc (PK)
US$ 0.0003
(50.00%)
109.47M
GTCHGBT Technologies Inc (PK)
US$ 0.00025
(-16.67%)
103.64M
BIEIPremier Biomedical Inc (PK)
US$ 0.001
(25.00%)
100.37M
CATV4Cable TV International Inc (PK)
US$ 0.0001
(0.00%)
99.24M

AGNPF Discussion

View Posts
McMagyar McMagyar 1 day ago
Long termVery bullishInsider ownershipHome runs possible And all roads lead to better treatments for dementiaI would throw in some homeopathic Opportunities as well.. really make it a no brainer service
👍️0
McMagyar McMagyar 4 days ago
Around 30,000,000 outHow much will a no brainer clinical sell for?How much income?I love itOne neuro group in every city
👍️0
shell3 shell3 7 days ago
Outstanding: 34,256,219 for June 10, 2025

Monthly 5th Report

https://webfiles.thecse.com/5._Algernon_-_CSE_Form_7_Monthly_Progress_Report_-_May_2025.pdf?dq.0S4or7PCmFbPRZOMr4cQr0q3znBY_
👍️0
shell3 shell3 2 weeks ago
MATERIAL CHANGE REPORT

The Acquisition cost some shares

5,000,000 Commons
5,000,000 Warrants @ $0.15 $AGN
which is $0.11 $AGNPF
450,000 Preferred (which convert to 10 Commons)
450,000 Preferred Warrants @ $1.50 $AGNPF

https://webfiles.thecse.com/AGN_-_material_change_report_-_NoBrainer_Acquisition_-_May_2025.pdf?TtUbNelliNHD6b47Dy5DEzEEQumgUbvI
👍️0
shell3 shell3 3 weeks ago
Issued and outstanding: 41,398,976 Shares issued and outstanding and 1,164,286 Preferred Shares to be issued upon shareholder
approval.

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_May_27_2025.pdf?7h0FADzO1U.f5j1GHZ1JtakX_vGULsLm

Here’s what came 1st to grow to 41.4M going to be Outstanding

https://webfiles.thecse.com/2._Algernon_CSE_Form_9_-_NoBrainer_Final.pdf?05nLb1ou6zdqlZ.W1bEwvqDMolSsF3r1
👍️0
shell3 shell3 1 month ago
Algernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer’s Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-to-Acquire-NoBrainer-Imaging-Centers-Inc---Plans-to-Establish-Alzheimers-Diagnostic-and-Treatment-Medical-Clini?id=477047
👍 2
shell3 shell3 1 month ago
Outstanding: 28,756,219 for May 7, 2025

Monthly 5th Report

https://webfiles.thecse.com/4._Algernon_-_CSE_Form_7_-_April_2025.pdf?yK._riJP7jXr1l.nsO3MzXWng_vAgmHu
👍️0
shell3 shell3 2 months ago
Outstanding: 28,706,219 for April 3, 2025

Monthly 5th Report

https://webfiles.thecse.com/3._Algernon_-_CSE_Form_7_-_March_2025.pdf?omj5DHVectn4mLlb3ERYaKOOSpvdsjd0

1.4M shares added to Outstanding and looks like JFK Enterprises Ltd. bought in under James Kinley in March
👍️0
shell3 shell3 2 months ago
Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Receives-Notice-of-Allowance-from-European-Patent-Office-for-Repirinast-for-Kidney-Disease?id=472899
👍️0
shell3 shell3 3 months ago
Planned Regulation A Financing

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-NeuroScience-Engages-Netcapital-Securities-for-Planned-Regulation-A-Financing?id=469774
👍️0
shell3 shell3 3 months ago
Outstanding: 27,301,219 for March 5, 2025

Monthly 5th Report

https://webfiles.thecse.com/2._Algernon_-_CSE_Form_7_-_February_2025.pdf?1m_UXQap03YYSE8UYvl4CojNGCX9St22
👍️0
shell3 shell3 4 months ago
DMT Study Set To Explore Breakthrough Potential in Stroke Recovery

https://www.streetwisereports.com/article/2025/02/14/dmt-study-set-to-explore-breakthrough-potential-in-stroke-recovery.html?utm_source=AGN-CNX
👍️0
shell3 shell3 4 months ago
Outstanding: 27,301,219 for February 10, 2025

Monthly 5th Report

https://webfiles.thecse.com/Algernon_-_CSE_Form_7_-_January_2025.pdf?vminj6YZTkivyUTkEksmv48BrU2v6MZq

Note #13 is a good read
👍️0
tcm7 tcm7 4 months ago
About Time for some Good news...

https://www.algernonpharmaceuticals.com/news-media/news-releases/detail/213/algernon-neuroscience-appoints-validcare-as-cro-for-its
👍️0
shell3 shell3 5 months ago
Outstanding: 27,301,179 for January 6, 2025

Monthly 5th Report

https://webfiles.thecse.com/12._Algernon_-_CSE_Form_7_-_December_2024.pdf?9VwETA1schKXaKZEJfJQcpdOsqeBCd5Q
👍️0
shell3 shell3 5 months ago
Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Receives-Notice-of-Allowance-from-USPTO-For-Repirinast-in-Kidney-Disease-Patent?id=463673
👍 1
shell3 shell3 6 months ago
Outstanding: 27,301,179 for December 17, 2024

Monthly 5th Report

https://webfiles.thecse.com/11._Algernon_-_CSE_Form_7_-_November_2024.pdf?8zodTJV77.vDjjF3CmUvo1WJ4a9O5bpu
👍️0
shell3 shell3 7 months ago
Outstanding: 27,301,179 for November 6, 2024

Monthly 5th Report

https://webfiles.thecse.com/10._Algernon_-_CSE_Form_7_-_October_2024.pdf?dcBppEBh75EfB.9rOF7uL_qdPPt86f8S

400 Warrants issued in October @ $0.52 $AGN or $0.374 $AGNPF price (Market never went over $0.0688 $AGNPF the whole month of October and Buying Open Market would have been like 2,000 shares vs the same cost of 400 Warrants)
👍️0
shell3 shell3 7 months ago
NOTICE OF AMENDMENT OF WARRANT TERMS

They expire November 5th and change the date to expire May 5th 2025

But look how they left the price unchanged from to still $0.52 $AGN or $0.374 $AGNPF

Looks Bullish but I DON’T FEEL IT

https://webfiles.thecse.com/Final_Algernon_CSE-Form_13-Amendment-of_Warrant_Terms_-_Nov._2024.pdf?QLyYlN5KeNvboxvVrkU5kuy7e1jImpz4
👍️0
LuckyMarble LuckyMarble 8 months ago
I have completely lost track of what might be next here with AGN. What are we waiting for? Is there anything going on at all? There is never any news, no video interviews, nothing to follow...what is potentially next???
👍️0
McMagyar McMagyar 8 months ago
I still like management AND this stock..
I know.. oh well..
buy low!
👍️0
McMagyar McMagyar 8 months ago
I am the worst stock picker ever..
Haha
👍️0
shell3 shell3 9 months ago
Outstanding: 27,300,779 for September 10, 2024

Monthly 5th Report

https://webfiles.thecse.com/8._Algernon_-_CSE_Form_7_-_August_2024.pdf?T0RnoT2MZl1XzWpHbNPjzdACkTKflj8P
👍️0
McMagyar McMagyar 10 months ago
Actually one of few stocks I would own at this point… God help us all if the Marxists win .. they usually kill people before they take power..
👍️0
McMagyar McMagyar 10 months ago
By all rights
The previous shareholders lost everything with failures..
You are buying a different proposition and insiders are invested..
It’s a better shot with DMT ..

I like it

Needed cash but if able will buy back in
👍️0
shell3 shell3 10 months ago
Offering is $0.0892 $AGNPF or $0.12 $AGN

Someone and Insiders Buying the Offering

But Insiders except Kinley has also sold most those others held on the last real run which does look bad and would expect them to also sell these bought when price is up - JMO

https://ceo.ca/agn
👍️0
McMagyar McMagyar 10 months ago
My thinking is
Don’t sell
👍️0
shell3 shell3 10 months ago
CRY or LAUGH My Ass Off

To me it’s sad but someone is collecting shares for some reason - Volume just not there for selling for the same @ the Market Price

Algernon Pharmaceuticals Announces Increase to Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, Aug. 13, 2024 (GLOBE NEWSWIRE)

https://webfiles.thecse.com/2024-08-13_Algernon_Pharmaceuticals_Announces_Increase_to_209.pdf?80FkHRyx35jcD3V97cSqfn8Fr.W2Qq5G
👍️0
shell3 shell3 10 months ago
Outstanding: 25,340,779 for August 7, 2024

Monthly 5th Report

https://webfiles.thecse.com/7._Algernon_-_CSE_Form_7_-_July_2024.pdf?xHwunyx5dN5BN0JDisNSwQ2.pH76QXG0
👍️0
shell3 shell3 10 months ago
Closing of Private Placement

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Announces-Closing-of-Private-Placement?id=448835
The Company paid cash finder’s fees totaling $5,376 and issued 44,800 finders warrants to eligible finders for investors introduced to the Company by the eligible finder.

Who Bought Shares ••• (Units)

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_August_2024_Final.pdf?MfzQpVMdcPsP0LHNMqkugZLHRQ9oMPG.
👍️0
shell3 shell3 10 months ago
Issued and outstanding securities following issuance:
👍️0
shell3 shell3 10 months ago
25,340,779 Shares Outstanding
👍️0
shell3 shell3 11 months ago
25.5M Outstanding if closing tomorrow doesn’t change


25,340,779 Outstanding if closing the same that was released today and it Close 08/01/2024

Add the Broker pay which probably some in Cash and again paid the same in shares

In the past it was 8% cash and 8% shares and should read the 1st notice of this Offering

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_Juy_2024.pdf?xwI_B_aF3yzpRKAETnDXGgVEQpZBtyNc

Says “To be provided @ the Closing, if any”
👍️0
shell3 shell3 11 months ago
Quarter just posted for 5/31/2024

https://www.otcmarkets.com/otcapi/company/financial-report/408374/content

And here’s the MD&A posted

https://www.otcmarkets.com/otcapi/company/financial-report/408376/content
👍️0
shell3 shell3 11 months ago
Algernon Announces Increase to Private Placement

Received a email just now but not posted yet OTC but here’s a quote and my math comes to 3,400,000 shares with Warrants the same plus Brokers fee paid in shares

announces an increase to its non-brokered private placement, previously announced on July 11, 2024, from gross proceeds of $250,000 to $408,000 (the “Offering”) of units (the “Units”) at an issue price of $0.12 per Unit. Each Unit will consist of one Class A common share in the capital of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to acquire one Common Share (a “Warrant Share”) at an exercise price of $0.24 per Warrant Share for a period of 2 years from the date of issuance (the “Expiry Date”), subject to acceleration of the Expiry Date as described below. The Offering is expected to close on August 1, 2024

That’s $0.12 is $AGN price or $0.087 $AGNPF for the Unit and Warrants are just doubled the price

P.S. ••• It just posted OTC

https://www.otcmarkets.com/stock/AGNPF/news/story?e&id=2933271
👍️0
shell3 shell3 11 months ago
Could This Stock Be the Next Bellus Cough Treatment?

https://www.streetwisereports.com/article/2024/07/17/could-this-stock-be-the-next-bellus-cough-treatment.html?utm_source=AGN-CNX
👍️0
smoki smoki 11 months ago
With all of the reverse splits .. my initial 50,000 shares is now 2,000. Lol go figure todays volume.
👍️0
smoki smoki 11 months ago
Looks like everyone split … 1,000 shares traded on some pretty good news
👍️0
shell3 shell3 11 months ago
Study Showing 93% Cough Suppression with Ifenprodil

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Reports-Results-of-Study-Showing-93-Cough-Suppression-with-Ifenprodil?id=446850
👍️0
shell3 shell3 11 months ago
2,083,333 Units Per this Filing

https://webfiles.thecse.com/Algernon_CSE_Form_9_-_Juy_2024.pdf?xwI_B_aF3yzpRKAETnDXGgVEQpZBtyNc
👍️0
shell3 shell3 11 months ago
Algernon Pharmaceuticals Announces Private Placement

https://www.otcmarkets.com/stock/AGNPF/news/Algernon-Pharmaceuticals-Announces-Private-Placement?id=446532

gross proceeds of $250,000 (the “Offering”) of units (the “Units”) at an issue price of $0.12 per Unit

And thats CAD not USD so that $0.088 $AGNPF
on roughly 2,083,784 more diluted shares
👍️0
shell3 shell3 11 months ago
Outstanding: 21,940,779 for July 10, 2024

Monthly 5th Report

https://webfiles.thecse.com/6._Algernon_-_CSE_Form_7_-_June_2024.pdf?75v3v4P.m.qiZNOTcs14RpT7cYj_RqOU
👍️0
McMagyar McMagyar 11 months ago
Thank you,
It’s a p1 ..
It’s over..
Let’s go P2..

👍️0
tcm55 tcm55 11 months ago
Dr Heijden did the presentation about CHDR at the Psychedelic conference,,,

https://www.icpr-conference.com/speakers/katelijne-van-der-heijden
👍️0
tcm55 tcm55 12 months ago
Seems the Defense Authorization bill has support for research using these drugs for PTSD and "wounds of war". TBA?
The Netherlands is also doing research along with Arizona, Texas and Oregon and more.
Come on Chris, present our research, tell us how it went and try to get us involved with this new funding...JMHFO...GLTA...

https://www.youtube.com/shorts/8b50ODFdMEY
👍️0
McMagyar McMagyar 1 year ago
Anyone have presentation?
👍️0
shell3 shell3 1 year ago
Outstanding: 21,940,779 for June 6, 2024

Monthly 5th Report

https://webfiles.thecse.com/5._Algernon_-_CSE_Form_7_-_May_2024.pdf?P_P1hgWsY8Cb0IuHXny8OiFIIn_NDM5g
👍️0
tcm55 tcm55 1 year ago
AGN presentation to CHDR later this week. Sure hope we can finally see some real interesting news...GLTA...
👍️0
smoki smoki 1 year ago
Doubled the $$$’s in 3 mo’s…gonna rocket!!!$$$
👍️0
shell3 shell3 1 year ago
Insiders look to be Adding Shares

https://ceo.ca/agn
👍️ 1

Your Recent History

Delayed Upgrade Clock